Search

everythinglearnresearchcommunity

for

Search:↓

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

Gefitinib therapy can cause unusual hair growth on the nose.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Lack of TG2 increases fat storage and lowers cell cleanup in skin oil cells.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Abrocitinib may effectively treat stubborn alopecia universalis.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

GLP-1 receptor agonists may help or harm hair health, needing more research.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Agarose/fucoidan hydrogels may help treat diabetes by supporting pancreatic cell growth.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Topical Ruxolitinib may safely treat severe hair loss.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Changes in SHBG levels don't predict diabetes risk reduction.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.